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Abstract
Background: Fibromyalgia (FM) affects approximately 1–3 % of the general population. Fatigue limits the work
ability and social life of patients with FM. A few studies of physical exercise have included measures of fatigue in
FM, indicating that exercise can decrease fatigue levels. There is limited knowledge about the effects of resistance
exercise on multiple dimensions of fatigue in FM. The present study is a sub-study of a multicenter randomized
controlled trial in women with FM. The purpose of the present sub-study was to examine the effects of a person-
centered progressive resistance exercise program on multiple dimensions of fatigue in women with FM, and to
investigate predictors of the potential change in fatigue.
Methods: A total of 130 women with FM (age 22–64 years) were included in this assessor-blinded randomized
controlled multicenter trial examining the effects of person-centered progressive resistance exercise compared with
an active control group. The intervention was performed twice a week for 15 weeks. Outcomes were five
dimensions of fatigue measured with the Multidimensional Fatigue Inventory (MFI-20). Information about background
was collected and the women also completed several health-related questionnaires. Multiple linear stepwise regression
was used to analyze predictors of change in fatigue in the total population.
Results: A higher improvement was found at the post-treatment examination for change in the resistance exercise
group, as compared to change in the active control group in the MFI-20 subscale of physical fatigue (resistance group
Δ –1.7, SD 4.3, controls Δ 0.0, SD 2.7, p = 0.013), with an effect size of 0.33. Sleep efficiency was the strongest predictor
of change in the MFI-20 subscale general fatigue (beta = −0.54, p = 0.031, R2 = 0.05). Participating in resistance exercise
(beta = 1.90, p = 0.010) and working fewer hours per week (beta = 0.84, p = 0.005) were independent significant
predictors of change in physical fatigue (R2 = 0.14).
Conclusions: Person-centered progressive resistance exercise improved physical fatigue in women with FM
when compared to an active control group.
Trial registration: ClinicalTrials.gov NCT01226784. Registered 21 October 2010.
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Background
The prevalence of fibromyalgia (FM) is approximately
1–3 % in the general population, increases with age, and
is more prevalent in women than in men [1]. In addition
to persistent widespread pain and allodynia, patients
with FM often experience severe fatigue, sleep distur-
bances, stiffness, psychological distress and/or cognitive
impairment [2–5]. Women with FM have been shown to
have impaired physical capacity [6–8] and they are also
less physically active compared to healthy controls [9].
FM is a dominating cause of sick leave among female
patients with musculoskeletal disorders and has a great
impact on quality of life [6, 10].
Fatigue is a prominent symptom in patients with FM,
which limits their work ability and social life [11–13].
Women with FM have described their fatigue in terms
of sleepless nights, physical weakness, social withdrawal,
loss of mental energy and overwhelming exhaustion
[13]. Socio-demographic aspects such as female gender,
younger age, low working capacity and low level of edu-
cation have been shown to be associated with higher
levels of fatigue in FM [14].
Fatigue is commonly assessed with a one-dimensional
visual analog scale (VAS), which enables comparisons
across studies. However, fatigue is a complex symptom
that interacts with several other common FM symptoms.
It is thus recommended to be assessed in multiple di-
mensions, such as physical, mental and general fatigue
in patients with FM, especially in non-pharmacological
studies [15, 16]. Fatigue has been shown to be associated
with increased distress, muscular tenderness, and poor
sleep quality [14, 15, 17, 18]. Higher ratings on the sub-
scales of physical fatigue and reduced activity, which are
included in the Multidimensional Fatigue Inventory
(MFI-20), have been associated with low working cap-
acity, low level of physical activity and impaired physical
capacity in women with FM [15, 19, 20].
Pain catastrophizing influences the perception of pain
and other symptoms in many patients with FM, which
complicates the treatment and could influence compli-
ance with exercise [21]. Catastrophic thinking has also
been suggested to have an influence on fatigue in FM
and in other chronic conditions. However previous re-
search on this topic is scarce [22].
The most beneficial treatment for FM requires a
multidisciplinary approach combining education,
pharmacological treatment, exercise and cognitive be-
havioral therapy [23, 24]. Exercise has been found to
improve feelings of energy and fatigue in various med-
ical conditions [25]. Different types of exercise are be-
ing used for treatment in FM and chronic widespread
pain (CWP) in health care, such as aerobic exercise,
resistance training, flexibility exercise and body aware-
ness therapy [26].
Few exercise studies have included measures of fatigue
in patients with FM. However the findings of these stud-
ies indicate that exercise could decrease fatigue levels
[26–29]. Aerobic exercise has been shown to improve
the MFI-20 dimension of reduced motivation in female
patients with FM [30, 31] and global outcome measures
of physical capacity and, to some degree, pain and the
number of tender points in FM [26].
Resistance exercise has shown positive effects on limi-
tations in activity, pain, global fatigue, depression and
muscle strength in patients with FM. However, the qual-
ity of evidence of these effects is poor due to the limited
number of studies [29]. The present study is a sub-study
of a randomized controlled trial (RCT) showing that re-
sistance exercise improved muscle strength, overall
health, and current pain intensity in women with FM,
when compared to an active control group [32]. The re-
sistance exercise intervention was a person-centered ap-
proach, which emphasizes active involvement of the
patient in planning the treatment that is suggested to
enhance the patient’s ability to manage health problems
[33]. The principles of person-centeredness were used in
the previously published RCT. The details of the exercise
program were planned together with each patient to
support each participant’s ability to manage the exercise
and the progression in loads [32].
As high levels of fatigue have been associated with low
levels of physical activity and impaired physical capacity
in FM [15, 19, 20], improvement in physical capacity in
patients with FM may result in a reduction in fatigue.
To our best knowledge, there is no previous study inves-
tigating the effects of resistance exercise on multiple di-
mensions of fatigue in FM.
The primary aim of the present study was to examine
the effects of a person-centered progressive resistance
exercise program on multiple dimensions of fatigue in
women with FM compared to an active control group,
and to investigate predictors of the potential change in
fatigue. Second, the effect of resistance exercise on sleep,
pain catastrophizing, depression, and anxiety were also
explored, as these variables have been shown previously
to be associated with fatigue.
Methods
Study design
This is a sub-study of a multicenter randomized controlled
trial in women with FM (ClinicalTrials.gov identification
number: NCT01226784) [32]. The present sub-study aimed
to investigate the effects of resistance exercise on multidi-
mensional fatigue in women with FM.
Recruitment
Inclusion and exclusion criteria have been described in
detail previously [32]. In short, the inclusion criteria
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were women aged 20–65 years, meeting the American
College of Rheumatology (ACR) 1990 classification cri-
teria for FM [2], and the exclusion criteria were other se-
vere somatic or psychiatric disorders, participation in a
rehabilitation program within the past year, or inability
to understand Swedish.
Female patients with FM were recruited by news-
paper advertisement in the local newspapers of three
cities in Sweden (Gothenburg, Stockholm, and Linköp-
ing) to the multicenter experimental study [32]. There
were 130 patients with FM included in the study, and
they were randomized to the resistance exercise group
(n = 67) or the active control group (n = 63). The
process of recruitment and randomization has been de-
scribed in detail in a previous publication [32]. No sig-
nificant differences were found in sociodemographic
data between the resistance exercise group (n = 67) and
the active control group (n = 63) (Fig. 1) [32].
All participants were invited to a post-treatment exam-
ination after 15 weeks and 84 % (n = 56) in the resistance
exercise group and 76 % (n = 49) in the active control
group completed the test. Seventeen participants (25 %)
in the resistance exercise group and 20 (32 %) in the ac-
tive control group discontinued the intervention due to
various reasons [32]. Five participants in the resistance
exercise group reported adverse effects and chose to dis-
continue the intervention due to increased pain. Two of
these participants completed post-treatment examina-
tions (Fig. 1). Modified figure from [32].
Interventions
Resistance exercise
The person-centered progressive resistance exercise
intervention was performed twice a week for 15 weeks
at physiotherapy premises and at a local gym and was
supervised by experienced physiotherapists. The exer-
cise program was standardized and performed in
groups of five to seven participants but the load was
adjusted individually. The exercise session started with
10 minutes of warm up followed by 50 minutes of re-
sistance exercises focused on large muscle groups in all
four extremities and trunk. The resistance exercise was
initiated at 40 % of 1 repetition maximum (RM) and
progressed up to 80 % of 1 RM during the 15 weeks.
Possibilities for progression of loads were evaluated
every 3–4 weeks. Forty-two participants (62.7 %) in the
resistance exercise group reached exercise loads of
80 % of 1 RM while seven participants (10.4 %) reached
exercise loads of 60 % of 1 RM. The median attendance
rate at the resistance exercise sessions was 71 % (range
0–100 %). The procedure of the resistance exercise and
adjustment of loads in the present study has been
described in detail previously [32].
Active control group
The active control treatment consisted of relaxation
therapy, which was performed twice a week for 15 weeks,
guided by experienced physiotherapists and conducted
at physiotherapy premises in groups of five to eight par-
ticipants. It was performed as autogenic training [34],
which refers to a series of mental exercises including
autosuggestion and relaxation. The relaxation therapy
lasted for approximately 25 minutes, followed by
stretching exercises. The median attendance rate at the
relaxation therapy sessions was 64 % (range 0–100 %).
The procedure in the active control group has been de-
scribed in detail previously [32].
Measurements
The patients were referred to a baseline examination
which included a tender-point examination [2] by a
physician, performance-based tests of physical capacity
conducted by physical therapists, and a battery of self-
reported questionnaires [32].
Background data
Background data such as age, education, employment,
duration of pain, sick leave, disability pension, and medi-
cation were obtained by a standardized interview. Dur-
ation of widespread pain was reported in years and
obtained by a standardized interview. Employment was
divided into four categories of percentage of full-time
work: 0 %; 1–49 %; 50–79 %; and 80–100 %. Full-time
work was defined as 40 h per week.
Self-reported questionnaires
Multidimensional Fatigue Inventory (4–20)
The MFI-20 comprises 20 statements on a 5-point Likert
scale that addresses aspects of fatigue experienced dur-
ing the most recent days. The scores generate five sub-
scales of fatigue: general fatigue, physical fatigue, mental
fatigue, reduced motivation, and reduced activity. The
scores range from 4 to 20 for each subscale and higher
scores refer to a higher degree of fatigue [35, 36]. The
MFI-20 has been shown to have satisfactory convergent
construct validity and test-retest reliability in FM [37].
FIQ fatigue (0–100)
The VAS for fatigue included in the Fibromyalgia Impact
Questionnaire (FIQ) [38] was used as a one-dimensional
measure of fatigue in this study, ranging from 0 mm (no
tiredness) to 100 mm (very tired). The FIQ for fatigue
has been validated and shown satisfactory test-retest reli-
ability in Swedish patients with FM [39].
FIQ pain (0–100)
The VAS for pain is a subscale of the FIQ that mea-
sures current pain intensity. The participant was
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asked to rate her current pain intensity, ranging
from 0 mm (no pain at all) to 100 mm (worst im-
aginable pain) [38]. The FIQ for pain was used only
in the analyses of predictors of potential change in
fatigue.
Pittsburgh Sleep Quality Index (PSQI) (0–21)
The PSQI assesses sleep quality and disturbances over
a 1-month period. It comprises nineteen items (scored
0–3), which constitute seven subscales: sleep quality,
sleep latency, sleep duration, sleep efficiency, sleep
Telephone screening (n=402)
Intent-to-treat population for analyses of 
changes from baseline to post-treatment 
(n=56)





Allocated to resistance exercise (n=67)
Received allocated intervention (n=50)
Discontinued allocated intervention (n=17)








Allocated to relaxation therapy (n=63)
Received allocated intervention (n=43)
Discontinued allocated intervention (n=20)
Never showed up (n=9)
Personal reasons (n=10)
Wanted resistance exercise training (n=1)
Intent-to-treat population for analyses of 
changes from baseline to post-treatment 
(n=49)
Randomization
Enrollment Not eligible (n=225)
Not meeting inclusion criteria (n=124)
Did not have FM (n=11)
Too old (n=1)
OA in hip or knee (n=13)
Other severe disorder (n=42)
Unable to participate in examinations (n=28)
Recent or planned surgery (n=6)
Exercise >2 times per week (n=8)
Ongoing rehabilitation program (n=4)
Not able to refrain from medication (n=10)
Not speaking Swedish (n=1)
Declined to participate: time limitations (n=40),
transport difficulties (n=12), not interested (n=49)
Assessed for eligibility at medical 
examination (n=177)
Completing baseline examination 
and randomization (n=130)
Excluded (n=47)
Not meeting inclusion criteria (n=28)
Did not have FM (n=14)
Other severe disorder (n=11)
Not being able to refrain from medication 
(n=3)
Declined to participate: time limitations (n=7),
not interested (n=12)
Post-treatment examinations
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) flow diagram of the progress of the two groups in the randomized trial. Modified
figure from [32]. FM fibromyalgia, OA osteoarthritis
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disturbances, need of medications to sleep (use of
sleeping medication) and daytime dysfunction. The
sum of scores for the seven subscales generate one total
score (0–21). A PSQI total score >5 indicates poor
sleep [40]. The PSQI has been used previously in stud-
ies of FM [41, 42].
Pain catastrophizing scale (PCS) (0–52)
The PCS assesses pain-related catastrophic thinking.
The patients estimate on a 5-point Likert scale (0 (not at
all) to 4 (all the time)) the extent to which they experi-
ence 13 thoughts or feelings while they feel pain. The
PCS total score (0–52) is the sum of the scores of the 13
items [43]. A PCS total score >24 displays a high level of
catastrophic thinking in patients with sub-acute
whiplash-related pain [44]. The 13 items also generate
three subscales; rumination, helplessness and magnifica-
tion [43]. The three PCS subscales and the total score
were used in the present study in between-group ana-
lyses of change over time, while only the PCS total score
was used in the analyses of predictors of change in fa-
tigue. The PCS has been tested for validity and reliability
[45, 46] and has been used in studies of FM [47–49]
Hospital Anxiety and Depression Scale (HADS) (0–21)
The HADS contains 14 statements, ranging from 0–3,
and a higher score refers to a higher degree of distress.
The scores of the 14 items build two subscales: HADS-
A for anxiety (0–21) and HADS-D for depression (0–21)
[50]. A cutoff score of 8 is suggested to indicate possible
anxiety or depression [51].
Tests of physical capacity
Leisure Time Physical Activity Instrument (LTPAI) (h)
The patients estimate their amount of physical activity
in leisure time during a typical week [52]. The physical
activities were divided into three categories: light, mod-
erate, and heavy activities, and examples of such activ-
ities were given for each category. The LTPAI total score
is the sum of hours in all three categories and was used
in the present study only in the analyses of potential pre-
dictors of change in fatigue.
The 6-minute walk test (6MWT) (m)
The patient was instructed to walk for 6 minutes as
quickly as she could without running and the total walk-
ing distance was measured [53]. The 6MWT was used in
the present study only in the analyses of potential pre-
dictors of change in fatigue.
Statistics
Data were computerized and analyzed using the Statis-
tical Package Software for the Social Sciences (SPSS ver-
sion 22, Chicago, IL, USA). Descriptive statistics are
presented as mean, standard deviation (SD) and range
for continuous variables and as number (n) and percent
(%) for categorical variables.
For comparison between two groups, normal distribu-
tion of data collected with questionnaires could not be
assumed and the non-parametric Mann–Whitney U test
was used for continuous variables, Mantel Haenszel chi-
squared test for ordered categorical variables and
Fisher’s exact test for dichotomous variables. Change
over time from baseline to 15 weeks within groups was
analyzed using the Wilcoxon signed rank test. Effect size
was calculated with Cohen’s d for outcomes showing a
significant change, by dividing the mean difference be-
tween the post-treatment score and baseline score in
the resistance exercise group and in the active control
group by the pooled SD for difference. Effect sizes from
0.20 to <0.50 were regarded as small and effect sizes
from 0.50 to <0.80 were regarded as moderate [54].
A baseline difference was found between the groups in
the PSQI subscale of sleep efficiency. The between-
group analyses were therefore adjusted for PSQI sleep
efficiency in linear regression analyses with outcome var-
iables (mean difference post treatment compared to
baseline) included as dependent variables and the group
variable (intervention/active control) and PSQI sleep ef-
ficiency included as independent variables. The assump-
tions of normality in regression analyses were confirmed
by checking the residual scatter plots and histograms of
each variable, respectively. To control for possible type 1
errors, the upper limit of the expected number of false
significant results for analyses of primary outcomes (the
five subscales of the MFI-20) was calculated by the fol-
lowing formula:
α=1 – α
 Number of tests – Number of significant testsð Þ;
where α is the significance level.
Correlation was assessed between the difference be-
tween post-treatment and baseline in the five subscales
of the MFI-20 and the baseline values for the variables
age, employment, duration of widespread pain, FIQ pain,
the PCS, the HADS, the PSQI, the LTPAI and the
6MWT, using Spearman’s correlation coefficient (rs).
These variables were chosen based on results from pre-
vious studies of correlation between fatigue and other
patient characteristics [15, 22]. In order to find inde-
pendent baseline predictors of change in fatigue for each
MFI-20 subscale, the variables with a Spearman’s correl-
ation p value p <0.1 with the MFI-20 subscale and group
of randomization were entered into a multiple linear
stepwise regression analysis with change in the fatigue
subscale as the dependent variable. Multiple linear step-
wise regression analyses were performed of the subscales
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of the MFI-20 that were found to be significantly corre-
lated with more than one variable. All tests were two-
sided and conducted at the 5 % significance level.
Results
Between-group comparisons
Results of between-group comparisons are shown in
Table 1.
Multidimensional fatigue
There was significantly greater improvement at the post-
treatment examination according to change in the MFI-
20 subscales for general fatigue (p = 0.031), physical
fatigue (p = 0.013) and mental fatigue (p = 0.008) in the
resistance exercise group, as compared to the change
over time in the active control group (Table 1). The
mean improvements in the resistance exercise group
from baseline to post treatment were 7.5 % in general fa-
tigue, 10.6 % in MFI-20 physical fatigue and 10.7 % in
mental fatigue. There were no statistically significant dif-
ferences between the two groups in change in the MFI-
20 subscales for reduced motivation or reduced activity
at the post-treatment examination (Table 1).
There was a baseline difference between the resistance
exercise group and the active control group in the PSQI
subscale of sleep efficiency (mean 1.9, SD 1.1 versus
mean 1.4, SD 1.2, p = 0.027) (Table 1). When the
between-group analyses of the MFI-20 were adjusted for
PSQI sleep efficiency, the difference between groups in
change of fatigue was significant only for the MFI-20
subscale physical fatigue (p = 0.044) (Table 1). The effect
size of change in MFI-20 for physical fatigue in the re-
sistance exercise group compared to the active control
group was 0.33 (i.e., a small effect size).
Type 1 error: the between-group analyses of primary
outcomes (the five subscales of the MFI-20) comprised a
total of five statistical analyses, with one significant value
at the significance level 0.05, and the upper level of the
number of false significance results was 0.21, which indi-
cates that 0–1 of the significant results observed might
be false.
Exploratory outcomes
No statistically significant differences were found be-
tween the resistance exercise group and the relaxation
group in change in the FIQ for fatigue, the PSQI, the
PCS or the HADS at the post-treatment examination
(Table 1).
Within-group analyses of exploratory outcomes, and
change from baseline to post treatment
Results of within-group analyses of outcomes, and
change from baseline to post treatment are shown in
Table 1.
The FIQ for fatigue
The resistance exercise group improved in the FIQ for
fatigue over time from baseline to post treatment (mean
difference −8.6, SD 21.2, p = 0.002) (Table 1).
The PSQI
The resistance exercise group improved over time in the
PSQI subscale for sleep quality (mean difference −0.2,
SD 0.8, p = 0.047), while the active control group im-
proved in the PSQI subscale for need of medications to
sleep (mean difference 0.3 SD 1.0, p = 0.036) (Table 1).
The PCS
The resistance exercise group improved significantly
over time in all three PCS subscales and the PCS total
score (mean difference in PCS total score −2.7 SD 7.6,
p = 0.004). In the active control group there was a ten-
dency towards improvement in two PCS subscales and
the PCS total score (p = 0.051–0.056) (Table 1).
The HADS
No significant changes during the study period were
found within any of the groups for HADS anxiety or
HADS depression (Table 1).
Predictors of change in fatigue
The baseline values of the variables included in the cor-
relation analysis are presented in Table 1 and in a previ-
ous publication [32]. The results of the correlation
analysis are presented in Table 2. Multiple linear step-
wise regression analyses were carried out on the sub-
scales of the MFI-20 that were found to be significantly
correlated with more than one variable, which were gen-
eral fatigue and physical fatigue. Variables correlated
with change in MFI-20 subscales with a p value <0.1
were included together with intervention group (resist-
ance/control) in the multiple linear stepwise regression
analyses of predictors of change in the MFI-20
subscales.
MFI-20 general fatigue
Intervention (resistance/control), employment, the PSQI
for sleep efficiency and the FIQ for pain were associated
(p < 0.1) with change in the MFI-20 for general fatigue
(Tables 1 and 2) and were included in the multiple linear
stepwise regression analysis for general fatigue. After the
PSQI for sleep efficiency was entered into the stepwise
model as the first variable, no additional variable was en-
tered (B = − 0.54, SE 0.25, p = 0.031). The R2 value for
the model was 0.05. Poorer sleep efficiency at baseline
predicted improvement in general fatigue.
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Table 1 Baseline values, change from baseline in outcome variables, and within-group and between-group differences in change in the resistance exercise group and the active
control group
Resistance exercise group Active control group Resistance vs active control group
Baseline n = 67
Mean (SD)
Δ 15 weeks n = 56
Mean (SD), min, max
Within-group
analysis p value
Baseline n = 63
Mean (SD)
Δ 15 weeks n = 49













General fatigue 17.3 (2.7) −1.3 (3.1), −10, – 7 0.003 17.8 (2.74) −0.5 (2.6), −9, – 4 0.48 0.17 0.031 0.37
Physical fatigue 16.0 (3.0) −1.7 (4.3), −13, – 8 0.011 16.5 (2.9) 0.0 (2.7), −8, – 5 0.66 0.29 0.013 0.044
Mental fatigue 15.0 (3.3) −1.6 (3.4), −10, – 7 0.001 15.0 (4.0) −0.1 (2.5), −6, – 5 0.85 0.56 0.008 0.070
Reduced activity 14.6 (3.4) −1.0 (3.6), −13, – 6 0.055 15.2 (3.5) −0.1 (2.8), −8, – 5 0.89 0.29 0.12 0.069
Reduced motivation 10.5 (3.5) −0.6 (3.7), −10, – 10 0.16 10.4 (3.6) 0.4 (2.8), −8, – 6 0.34 0.78 0.061 0.32
Exploratory outcomes
FIQ fatigue 81.4 (17.3) −8.6 (21.2), −87, – 66 0.002 81.8 (15.8) −5.5 (19.0), −81, – 73 0.11 0.95 0.27 0.18
PSQI
Duration of sleep 1.1 (1.1) −0.0 (0.9), −3, – 3 0.73 1.1 (1.2) −0.2 (0.9), −2, – 2 0.22 0.94 0.46 0.26
Sleep efficiency 1.9 (1.1) −0.3 (1.0), −3, – 1 0.061 1.4 (1.2) 0.1 (1.2), −2, – 3 0.55 0.027 0.14 0.37
Sleep disturbance 2.0 (0.6) 0.0 (0.6), −1, – 1 1.00 2.0 (0.6) 0.1 (0.6), −1, – 1 0.35 0.89 0.50 0.37
Sleep latency 1.7 (1.0) −0.1 (0.8), −2, – 1 0.26 1.8 (1.0) 0.0 (0.8), −2,– 2 0.84 0.83 0.53 0.32
Day dysfunction 1.6 (0.8) −0.1 (0.8), −2, – 2 0.45 1.7 (0.8) 0.0 (0.8), −2, – 2 1.00 0.49 0.64 0.65
Sleep quality 1.8 (0.8) −0.2 (0.8), −2, – 1 0.047 1.9 (0.8) 0.0 (0.8), −1, – 2 0.69 0.90 0.19 0.16
Need meds to sleep 1.0 (1.3) −0.1 (1.2), −3, – 3 0.69 1.0 (1.3) 0.3 (1.0), −2, – 3 0.036 0.82 0.27 0.10
PSQI total score 10.9 (4.3) −0.6 (3.4), −11, – 9 0.18 10.8 (4.0) 0.5 (3.0), −5, – 9 0.48 0.76 0.13 0.23
PCS
Rumination 6.3 (3.6) −0.9 (3.5), −8, – 12 0.046 6.6 (4.3) −0.8 (3.2), −8, – 10 0.056 0.81 0.97 0.11
Magnification 3.4 (2.5) −0.6 (1.9), − 4, – 4 0.030 3.6 (2.8) −0.4 (2.0), −5, – 3 0.25 0.82 0.50 0.18
Helplessness 9.7 (5.3) −1.3 (4.0), −10, – 9 0.012 10.1 (5.9) −1.6 (4.6), −15, – 6 0.051 0.84 0.84 0.49
PCS total score 19.4 (10.0) −2.7 (7.6), −17, – 19 0.004 20.3 (11.9) −2.8 (7.9), −25, – 11 0.055 0.88 0.58 0.16
HADS
Depression 7.0 (3.9) −0.7 (3.7), −9, – 11 0.086 6.7 (3.5) 0.3 (2.8), −6, – 12 0.49 0.80 0.082 0.11
Anxiety 7.9 (4.7) −0.3 (3.6), − 11, – 8 0.58 8.0 (4.5) 0.5 (2.7), − 9, – 8 0.10 0.94 0.22 0.099
MFI-20 Multidimensional Fatigue Inventory, FIQ Fibromyalgia Impact Questionnaire, PSQI Pittsburgh Sleep Quality Index, PCS Pain Catastrophizing Scale, HADS Hospital Anxiety and Depression Scale
*p value adjusted for PSQI sleep efficiency














Intervention (resistance/control), employment and the
PSQI for sleep efficiency were associated (p < 0.1) with
change in the MFI-20 for physical fatigue (Tables 1, 2)
and were included in multiple linear stepwise regression
analysis of physical fatigue. Intervention (B = 1.90, SE =
0.73, p = 0.010) and employment status (B = 0.8, SE =
0.29, p = 0.005) were independent predictors of change
in physical fatigue; R2 for the model was 0.14. Participat-
ing in the resistance exercise intervention and working
fewer hours per week at baseline predicted improvement
in physical fatigue.
Discussion
The present randomized controlled trial investigated the
effects of a 15-week person-centered progressive resist-
ance exercise program on multiple dimensions of fatigue
in 130 women with FM. Significant improvements were
found for change in the MFI-20 subscales for general fa-
tigue, physical fatigue, and mental fatigue in the resist-
ance exercise group in comparison with the active
control group. When the analyses were adjusted for
baseline differences in sleep efficiency the between-
group difference was significant for MFI-20 physical fa-
tigue only. The effect size for MFI-20 physical fatigue
was small (0.33) but lies within the expected range
according to a recent meta-analysis, which investigated
the effects of exercise on fatigue in patients with FM
[55]. The MFI-20 physical subscale reflects fatigue re-
lated to “physical ability to do things” and “physical con-
dition”, physical components that are expected to
improve with exercise. Although the improvement in
physical fatigue was small in effect size, it is valuable for
patients describing themselves as physically weak and
becoming fatigued after doing very little [56], which
causes deterioration in their quality of life and ability to
manage daily activities. The MFI-20 subscale for physical
fatigue has been used separately by the Outcome Mea-
sures in Rheumatology (OMERACT) group in analyses
aiming to identify subgroups in FM [57].
A previous study found that decreased fatigue in pa-
tients with FM engaging in exercise was associated with
changes in adipokines and insulin-like growth factor-1,
which appear to be biological correlates of exercise and
fatigue [58]. We were also interested in investigating
which variables could predict the possible change in fa-
tigue. Participating in resistance exercise combined with
working fewer hours per week at baseline predicted
greater improvement in the MFI-20 subscale for physical
fatigue. The PSQI for sleep efficiency predicted improve-
ment in the MFI-20 for general fatigue, which indicates
that the women with FM who had worse sleep efficiency
Table 2 Spearman’s correlation coefficients (rs) with p values for correlation between change (posttest-baseline) in the five subscales
of the Multidimensional Fatigue Inventory-20 and patient characteristics, symptoms and physical function (n = 105)
Change in general
fatigue rs, p value
Change in physical
fatigue rs, p value
Change in mental
fatigue rs, p value
Change in reduced
activity rs, p value
Change in reduced
motivation rs, p value
Age −0.09, 0.36 0.00, 0.98 0.01, 0.89 0.027, 0.78 0.033, 0.74
Employment 0.23, 0.021 0.26, 0.008 0.09, 0.35 0.11, 0.28 0.05, 0.62
Duration CWP 0.00, 0.98 −0.07, 0.47 0.04, 0.70 0.10, 0.33 0.10, 0.33
FIQ pain −0.17, 0.079 −0.14, 0.15 0.15, 0.12 −0.12, 0.23 0.02, 0.85
PCS total 0.02, 0.84 0.03, 0.80 0.02, 0.86 −0.04, 0.69 0.09, 0.39
HADS-D 0.00, 0.98 −0.02, 0.83 −0.12, 0.21 0.04, 0.70 −0.030, 0.76
HADS-A 0.06, 0.52 0.11, 0.26 −0.11, 0.28 0.14, 0.16 0.12, 0.24
PSQI
Duration of sleep −0.02, 0.84 −0.06, 0.55 −0.09, 0.39 −0.06, 0.58 −0.10, 0.36
Sleep efficiency −0.21, 0.049 −0.21, 0.044 −0.21, 0.048 −0.06, 0.54 −0.22, 0.037
Sleep disturbance −0.03, 0.74 0.09, 0.39 0.04, 0.67 0.16, 0.12 0.04, 0.69
Sleep latency −0.15, 0.15 −0.05, 0.62 −0.05, 0.66 −0.08, 0.46 −0.07, 0.54
Day dysfunction 0.06, 0.52 0.03, 0.74 0.00, 0.95 −0.08, 0.40 0.14, 0.18
Sleep quality −0.03, 0.75 −0.02, 0.84 −0.05, 0.63 0.05, 0.63 0.14, 0.17
Need meds to sleep −0.14, 0.15 −0.08, 0.41 −0.11, 0.28 0.00, 0.99 0.03, 0.80
Total score −0.10, 0.31 −0.11, 0.30 −0.13, 0.20 −0.06, 0.53 −0.4, 0.67
LTPAI −0.09, 0.38 0.08, 0.44 −0.02, 0.83 0.11, 0.29 −0.04, 0.69
6-minute walk test 0.06, 0.53 0.10, 0.33 −0.09, 0.35 −0.04, 0.71 −0.13, 0.19
Correlation coefficients with a p value <0.1 are marked in bold print. CWP chronic widespread pain, FIQ Fibromyalgia Impact Questionnaire, PCS Pain
Catastrophizing Scale, HADS-D Hospital Anxiety and Depression Scale – subscale of depression, HADS-A Hospital Anxiety and Depression Scale – subscale of
anxiety, PSQI Pittsburgh Sleep Quality Index, meds medications, LTPAI Leisure Time Physical Activity Instrument
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at baseline were more likely to improve their general fa-
tigue regardless of whether they participated in resist-
ance exercise or in the active control group. Sleep
efficiency in the PSQI refers to the time asleep per night
in relation to the time spent in bed. These findings indi-
cate that women with FM who have the worst sleep effi-
ciency might have the most to gain from any
intervention. However, the explained variance ranged
from 5 –4 % in the analyses of the MFI-20 subscales,
and the improvement in fatigue was reasonably influ-
enced by other factors not investigated in the present
study.
Variables that have been previously found to be associ-
ated with dimensions of fatigue were included in the
correlation analyses; however, only a few variables ap-
peared to be associated with change over time in fatigue.
The participants’ age or duration of pain did not appear
to have an influence on change in fatigue, nor did their
level of psychological distress or physical capacity. These
results indicate that women with FM could gain im-
provements in fatigue by resistance exercise regardless
of individual factors. Similar results have also been
found for improvements in pain disability [59].
Fatigue is a symptom with a great negative effect on
daily life in women with FM [11, 13, 60] and has been
recommended to be assessed in multiple dimensions
[15, 61], yet the effects of resistance exercise on multidi-
mensional fatigue in FM have not been previously stud-
ied. However, a few studies have investigated the effect
of resistance exercise on global fatigue assessed with a
VAS [62, 63]. In the present study the FIQ for global fa-
tigue was included for exploratory analysis. There was
significant improvement in the FIQ for global fatigue
within the resistance exercise group but there were no
significant differences in change in the FIQ for global fa-
tigue between the resistance exercise group and the con-
trol group. These results are in line with previous
studies by Jones et al. [62] comparing resistance exercise
with flexibility exercise, and by Häkkinen et al. [63] com-
paring resistance exercise with a control group in FM;
both studies showed a significant change within the re-
sistance exercise group in a VAS for global fatigue, but
there were no significant differences in the change in
global fatigue in comparison with controls. These find-
ings endorse the use of a multidimensional assessment
of fatigue in terms of physical fatigue, which was sensi-
tive to change induced by resistance exercise.
Exploratory analyses were carried out in the present
study aiming at investigating the effects of resistance ex-
ercise on the PSQI, the PCS and the HADS as compared
to the active control group. In the analyses of change
over time in the PSQI, the resistance exercise group had
significant within-group improvements in the subscale
for sleep quality and the active control group reported
significant improvement in the subscale for needing
medications to sleep, after the 15-week intervention.
However, there were no significant between-group dif-
ferences in change for any of the PSQI subscales. This is
line with the results of a previous study of resistance ex-
ercise in women with FM [63].
There were significant within-group improvements
over time in pain catastrophizing in the PCS total score
and all three subscales in the resistance exercise group.
However, there were no significant between-group dif-
ferences in change, possibly because the control group
also tended towards improvement in the PCS.
No significant changes were found for change in de-
pression or anxiety assessed with the HADS in the re-
sistance exercise group or the active control group. Also
in previous exercise studies, the effect on depression and
anxiety in FM has been found to be limited [31, 64].
Recent publications have recommended resistance ex-
ercise for patients with FM [65, 66]. The resistance exer-
cise program in the present study had a person-centered
approach and was progressively increased over 15 weeks.
Over 60 % of the participants managed to increase the
loads up to 80 % of 1 RM and the attendance was satis-
factory at 71 %. Only 5 (7 %) of the participants in the
resistance exercise group discontinued the intervention
due to increased pain, which indicates that a majority of
women with FM tolerate individually tailored resistance
exercise twice a week for over 3 months. The resistance
exercise program had a person-centered approach,
which most likely contributed to the high attendance
rate and low occurrence of adverse effects, as the ap-
proach enhances self-efficacy and sense of control in the
participants. The resistance exercise program in the
present study had similarities with the programs in the
studies by Jones et al. [62] and Häkkinen et al. [63],
which also were progressed and performed twice a week
[62]. Relaxation therapy was chosen as the active control
treatment in the present study and was assumed to im-
prove overall wellbeing in the women with FM.
Limitations
The present study is a sub-study and the statistical
power was calculated with regards to the primary ana-
lysis published previously [32]. The number of included
participants was also considered to be sufficient for the
aim of the present study, and there was a significant dif-
ference between the groups in change in physical fatigue.
The results of the present study must be interpreted
with caution because the upper limit of the expected
number of false significant results was calculated to be
0.21 for the primary outcomes, which indicates that 0–1
of the significant results could be false. A large number
of tests of correlation were also performed in the ana-
lyses of predictors, and the values of explained variance
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(R2) in the multiple linear regression analyses were low,
ranging from 0.05 to 0.14, which could be in the margin
of error for the subscales.
Positive expectations of exercise have been found to
play a role in the effect of exercise on psychological out-
comes [67]. The participants in the present study were
recruited by newspaper advertisement, which could have
attracted persons with FM with expectations of improve-
ment and a positive attitude towards resistance exercise.
This might have influenced the magnitude of improve-
ment and compliance with the exercise protocol. How-
ever, the same recruitment method was used for both
groups and they were recruited simultaneously, thus the
recruitment method would not have affected the out-
come in group comparisons.
Conclusions
The present study is the first to show that person-
centered progressive resistance exercise contributed to
improvement in physical fatigue in women with FM. As-
pects of work and sleep were found to contribute to the
improvement in fatigue.
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